Document is current
Any future updates will be listed below
-
Authors
Cifuentes, Guadalupe A. https://orcid.org/0000-0002-0042-0051
Santiago, Adrián
Méndez Blanco, Lucía
Fueyo, María
López Martínez, Esther
Soria, Raquel
Martín López, Irene
Cucarella Beltrán, Pepa
Pardo-Coto, Pablo
Rodriguez-Rubi, David
Urquilla, Karla
Durán, Noelia S.
Álvarez, Rebeca
Lago, Claudia G.
Otero, Andrea
Diñeiro, Marta
Capín, Raquel
Cadiñanos, Juan https://orcid.org/0000-0001-7561-7759
Cabanillas, Rubén https://orcid.org/0000-0003-3084-7766
- License Information
-
More Information
Article History
Received: 22 June 2022
Revised: 29 November 2022
Accepted: 2 December 2022
First Online: 22 December 2022
Competing interests
: ONCOgenics<sup>TM</sup> panels were developed and are owned by IMOMA.
: The study was approved by the competent ethics committee (Comité de Ética de la Investigación del Principado de Asturias, Project# 88/17). All patients provided written informed consent to participate.
